Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-9.43M.
ENTERPRISE VALUE (EV)
$-9.43M
Phio Pharmaceuticals Corp.
Market Cap
$11.61M
Enterprise Value (EV)
$-9.43M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.61M | $-9.43M |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.46M | $4.71M |
| Biofrontera Inc. (BFRI)vs › | $11.41M | $14.26M |
| Pluri Inc. (PLUR)vs › | $11.33M | $42.71M |
| BioVie Inc. (BIVI)vs › | $11.12M | $2.42M |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.11M | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.12M | $11.45M |
| Cerenome, Inc. (CNSY)vs › | $10.94M | $8.62M |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.40M | $5.57M |
| Lantern Pharma Inc. (LTRN)vs › | $12.47M | $5.85M |
Market Cap
$11.61M
Total Debt
$0.00
Cash
$21.03M
Enterprise Value
$-9.43M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
